Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1998-08-18
2000-11-14
Salimi, Ali
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
536 236, 536 234, 536 232, 5303919, 530326, 530350, C12P 2102
Patent
active
061468509
ABSTRACT:
The present invention provides purified proteins that contain gelonin amino acid sequences that have enzymatic activity.
REFERENCES:
patent: 4675382 (1987-06-01), Murphy
patent: 4769326 (1988-09-01), Rutter
patent: 4853871 (1989-08-01), Pantoliano et al.
patent: 4888415 (1989-12-01), Lambert et al.
patent: 4894443 (1990-01-01), Greenfield et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5013653 (1991-05-01), Huston et al.
patent: 5028530 (1991-07-01), Lai et al.
patent: 5091513 (1992-02-01), Huston et al.
patent: 5093475 (1992-03-01), Carroll et al.
patent: 5101025 (1992-03-01), Piatak, Jr. et al.
patent: 5169939 (1992-12-01), Gefter et al.
patent: 5376546 (1994-12-01), Bernhard et al.
patent: 5416202 (1995-05-01), Bernhard et al.
patent: 5621083 (1997-04-01), Better et al.
patent: 5624827 (1997-04-01), Rosenblum et al.
patent: 5631348 (1997-05-01), Rosenblum et al.
patent: 5744580 (1998-04-01), Better et al.
patent: 5756699 (1998-05-01), Better et al.
Hertler, A.A., and Frankel, A.E., "Immunotoxins: a clinical review of their use in the treatment of malignancies," J. Clin. Oncol. 7:1932-1942 (Dec. 1989).
Shaw, P.-C., et al.., "Cloning of trichosanthin cDNA and its expression im Escherichia coli," Gene 97:267-272 (Jan. 1991).
Dialog file 351, Derwent World Patents Index, English Language abstract for EP 192002 A1, WPI Accession No. 86-226683.
Antin, J.H. et al., Blood, 78 (8): 2139-2149 (Oct. 1991) "Selective Depletion of Bone Marrow T Lymphocytes With Anti-CD5 Monoclonal Antibodies: Effective Prophylaxis for Graft-Versus-Host Disease in Patients With Hematologic Malignancies".
Asano, K. et al., Carlsberg Res. Comm., 49: 619-626 (1984) "Isolation and Characterization of Inhibitors of Animal Cell-Free Protein Synthesis from Barley Seeds".
Bacha, P. et al., J. Exp. Med., 167: 612-622 (Feb. 1988) "Interleukin 2 Receptor-Targeted Cytotoxicity".
Barry B.W. ed, Dermatological Formulations--Percutaneous Absorption, Marcel Dekker, Inc., Pub., New York p. 180-181 (1983).
Batra, J.K. et al., J. Biol. Chem., 265 (25): 15198-15202 (Sep. 1990) "Anti-Tac(Fv)-PE40, a Single Chain Antibody Pseudomonas Fusion Protein Directed at Interleukin 2 Receptor Bearing Cells".
Batra, J.K. et al., Mol. and Cell. Biology, 11: 2200-2205 (Apr. 1991) "Single-Chain Immunotoxins Directed at the Human Transferrin Receptor Containing Pseudomonas Exotoxin A or Diphtheria Toxin: Anti-TFR(Fv)-PE40 and DT388-Anti-TFR(Fv)".
Benatti, L. et al., Eur. J. Biochem., 183: 465-470 (1989) "Nucleotide sequence of cDNA coding for saporin-6, a type-1 ribosome-inactivating protein from Saponaria officinalis".
Bernhard, S.L. et al., Bioconjugate Chem., 5 (2):126-132 (Mar. 1994) "Cysteine Analogs of Recombinant Barley Ribosome Inactivating Protein Form Antibody Conjugates with Enhanced Stability and Potency in Vitro".
Better, M. et al., Science, 240: 1041-1043 (May 1988) "Escherichia coli Secretion of an Active Chimeric Antibody Fragment".
Better, M. et al., 3rd Int'l Symposium on Immunotoxins, Jun. 19-21, 1992 Orlando, FL Generation of Potent Immunoconjugates from Microbially Produced Fab'. F(ab').sub.2, and Recombinant Ribosome Inactivating Proteins (Poster).
Better, M. et al., J. Biol. Chem., 267 (23): 16712-16718 (Aug. 1992) "Activity of Recombinant Mitogillin and Mitogillin Immunoconjugates".
Better, M. et al., Proc. Natl. Acad. Sci. USA, 90: 457-461 (Jan. 1993) "Potent Anti-CD5 Ricin A Immunoconjugates from Bacterially Produced Fab' and F(ab').sub.2 ".
Better, M. et al., J. Biol. Chem., 269 (13): 9644-9650 (Apr. 1994) "Gelonin Analogs with Engineered Cysteine Residues Form Antibody Immunoconjugates with Unique Properties".
Blakey, D.C. et al., Monoclonal Antibody Therapy. Prog. Allergy, 45: 50-90 (1988) "Antibody Toxin Conjugates: A Perspective".
Bolognesi, A. et al., Clin. Exp. Immunol., 89:341-346 (Sep. 1992) "A Comparison of Anti-Lymphocyte Immunotoxins Containing Different Ribosome-Inactivating Proteins and Antibodies".
Brown, D. et al. The Washington Post, A1 and A4, Aug. 21, 1992 "Customizing Lab Mice".
Byers, V.S. et al., Blood, 75:1426-1432 (Apr. 1990) "Use of an Anti-Pan T-Lymphocyte Ricin A Chain Immunotoxin in Steroid-Resistant Acute Graft-Versus-Host Disease".
Caron, P.C. et al., J. Exp. Med. 176:1191-1195 (Oct. 1992) "Engineered Humanized Dimeric Forms of IgG Are More Effective Antibodies".
Casellas, P. et al., Blood 65 (2):289-297 (Feb. 1985) "Optimal Elimination of Leukemic T Cells From Human Bone Marrow With T101-Ricin-A-Chain Immunotoxin".
Chaudhary, V.K. et al., Nature, 339: 394-397 (Jun. 1989) "A Recombinant Immunotoxin Consisting of Two Antibody Variable Domains Fused to Pseudomonas Exotoxin".
Cheadle, C. et al., Mol. Immunol., 29 (1): 21-30 (Jan. 1992) "Cloning and Expression of the Variable Regions of Mouse Myeloma Protein MOPC315 in E. Coli: Recovery of Active F.sub.v Fragments".
Chow, T. et al., J. Biol. Chem., 265: 8670-8674 (May 1990) "Isolation and DNA Sequence of a Gene Encoding .alpha.-Trichosanthin, a Type I Ribosome-inactivating Protein*".
Co, M.S. et al., Proc. Nat. Acad. Sci.USA, 88: 2869-2873 (Apr. 1991) "Humanized antibodies for antiviral therapy".
Colombatti, M. et al., J. Immunol., 131 (6): 3091-3095 (Dec. 1983) "Selective Killing of Target Cells By Antibody-Ricin A Chain or Antibody-Gelonin Hybrid Molecules: Comparison of Cytotoxic Potency and Use in Immunoselection Procedures".
Delprino, L. et al., Journal of Pharmaceutical Sciences, 82 (7):699-704 (Jul. 1993) "Toxin-Targeted Design for Anticancer Therapy. II: Preparation and Biological Comparison of Different Chemically Linked Gelonin-Antibody Conjugates".
Descotes, G. et al., J. Immunopharmac., 7 (4): 455-463 (1985) "The Immunological Activity of Plant Toxins Used in the Preparation of Immunotoxins--II. The Immunodepressive Activity of Gelonin".
Dower, W.J. et al., Nucleic Acids Res., 16 (13): 6127-6145 (1988) "High efficiency transformation of E. coli by high voltage electroporation".
Ebert, R.F. et al. , Bioconjugate Chem., 1: 331-336 (Feb. 1990) "Immunotoxin Construction with a Ribosome-Inactivating Protein from Barley".
Ellman G.L., Arch. Biochem. Bipophys., 82: 70-77 (1959) "Tissue Sulfhydryl Groups".
Fishwild, D.M. et al., Clin and Exp. Immunol., 86: 506-513 (Dec. 1991) "Cytotoxicity Against Human Peripheral Blood Mononuclear Cells and T Cell Lines Mediated By Anti-T Cell Immunotoxins in the Absence of Added Potentiator".
Fishwild, D.M. et al., Clin. Exp. Immunol., 97: 10-18 (Jul. 1994) "Characterization of the Increased Cytotoxicity of Gelonin Anti-T Cell Immunoconjugates Compared with Ricin A Chain Immunoconjugates".
Glockshuber, R. et al., Biochemistry, 29: 1362-1367 (Feb. 1990) "A Comparison of Strategies To Stablize Immunoglobulin F.sup.v -Fragments".
Goff, D.A. et al., Bioconjugate Chem., 1: 381-386 (Jan. 1991) "Substituted 2-Iminothiolanes: Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased Stability".
Habuka, N. et al., J. Biol. Chem., 264 (12): 6629-6637 (Apr. 1989) "Amino Acid Sequence of Mirabilis Antiviral Protein, Total Synthesis of Its Gene and Expression in Escherichia coli".
Halling, K.C. et al., Nucleic Acids Res., 13 (22): 8019-8033 (1985) "Genomic cloning and characterization of a ricin gene from Ricinus communis".
Harris, P. et al., Cellular Immunology, 134:85-95 (Apr. 1991) "In Vitro Studies of the Effect of MAb NDA 4 Linked to Toxin on the Proliferation of a Human EBV-Transformed Lymphoblastoid B Cell Line and of Gibbon MLA Leukemia Cell Line".
Ho, W.K. et al., Biochem. Biophys. Acta, 1088: 311-314 (Feb. 1991) "Cloning of the cDNA of .alpha.-momorcharin: a ribosome inactivating protein".
Huston, J.S. et al., Proc. Natl. Acad. Sci. USA, 85: 5879-5883 (Aug. 1988) "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli".
Islam, M.R. et al., Agricultural Biological Chem., 54 (5): 1343-1345 (May 1990) "Complete Amino Acid Sequence of Luffin-a, a Ribosome-inactivating Protein from the Seeds of Luffa cylindrica*".
Izzo, P. et al., Eur.
Better Marc D.
Carroll Stephen F.
Salimi Ali
Xoma Corporation
LandOfFree
Proteins encoding gelonin sequences does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins encoding gelonin sequences, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins encoding gelonin sequences will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2063803